Objective To determine the benefits and harms of subacromial decompression surgery in adult patients with subacromial pain syndrome lasting for more than 3 months. Design Systematic review with ...

Arthroscopic subacromial decompression surgery does not reduce pain any more than arthroscopy alone in people with shoulder impingement, researchers say. "[T]he findings from our study suggest that ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Published results showed patients with shoulder ...

POSIMIR ® (bupivacaine solution) for infiltration use reduced mean pain over 72 hours after arthroscopic subacromial decompression surgery compared with vehicle control and improved several measures ...

Please provide your email address to receive an email when new articles are posted on . Subacromial decompression with arthroscopic rotator cuff repair yielded a 21% risk reduction for revision ...

Research investigating a popular form of surgery aimed at easing chronic shoulder pain doesn't fix the problem, a careful, placebo-controlled study suggests. In the condition known as shoulder ...

Patients who undergo subacromial decompression surgery for shoulder impingement syndrome experience equally little pain when compared to a placebo surgery group, according to the Finnish Shoulder ...

Tim Jones receives funding from the National Institute for Health Research (NIHR), Department of Health and Social Care, UK. The views expressed in this article are those of the author(s) and not ...

The revision of CPT 29826 from a standalone code to an add-on code — +29826 (Arthroscopy, shoulder, surgical; decompression of subacromial space with partial acromioplasty, with coracoacromial ...

1 Department of Medical and Health Sciences, Division of Physiotherapy, Linköping University, SE-581 83, Linköping, Sweden 2 Department of Orthopaedics, University Hospital, SE-581 85, Linköping STUDY ...

CUPERTINO, Calif., Feb. 2, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration (FDA) has approved POSIMIR® (bupivacaine solution) for ...

An opioid-sparing protocol successfully reduces the need for opioid medication after outpatient arthroscopic knee or shoulder surgery, new research suggests. In a randomized clinical trial that ...